- Advertisement -

Bioconjugates Meet and Promise to Exceed Expectations

One of the fastest-growing segments of pharmaceuticals, as highlighted at the 2024 J.P. Morgan Healthcare Conference, is the antibody-drug conjugate (ADC) segment. ADCs consist...

Panelists Discuss Ethics of Biotechnology at Science, Technology, and Society Symposium | News – Harvard Crimson

Medical and legal authorities spoke about the ethics and future of biotechnology at a Friday panel hosted by the Program on Science, Technology, and...

MGI’s Innovative Technologies Is Enabling Sequencing of First Plant Species in The African BioGenome Project

From MGISep 18 2023 Cape Town, South Africa, 13 September2023 – MGI, a company committed to building core tools and technology to lead life science,...

NAU scientist collaborating on vault-based vaccine to prevent and treat COVID-19

Reviewed by Emily Henderson, B.Sc.Jun 1 2020 C. Todd French, assistant professor of biology and leader of Northern Arizona University's new COVID-19 Testing Service Center...

Can Encodia Become the Illumina of Proteomics?

With the astonishing progress in genomics and next-gen sequencing (NGS) over the past two decades, it is little wonder that researchers and entrepreneurs have...

StockWatch: Investors Unfazed by Illumina’s MiSeq Product Launches, Starboard’s $1B Stake...

It happens in Hollywood and on Broadway: Sometimes a great production wins mostly positive reviews from the critics but fails to wow the audience. The...

Beyond the Technology: AI Readiness in Regulated Laboratories

Artificial intelligence readiness involves much more than upgrading technology. For laboratories operating in regulated environments, it requires connected workflows, trusted data, effective human oversight,...

Receptor.AI and Sethera Plan to Create Closed-Loop Discovery and Optimization Workflow...

Receptor.AI and Sethera partner to create a closed-loop drug discovery workflow. Sethera will generate and experimentally screen architecture-diverse polymacrocyclic peptide libraries. Receptor.AI will apply...

Beyond the Technology: AI Readiness in Regulated Laboratories

Artificial intelligence readiness involves much more than upgrading technology. For laboratories operating in regulated environments, it requires connected workflows, trusted data, effective human oversight,...

Receptor.AI and Sethera Plan to Create Closed-Loop Discovery and Optimization Workflow for Difficult Therapeutic...

Receptor.AI and Sethera partner to create a closed-loop drug discovery workflow. Sethera will generate and experimentally screen architecture-diverse polymacrocyclic peptide libraries. Receptor.AI will apply...

Axiom’s Hong Kong Bet, Latigo’s Positive Phase II, and Base Editors for Huntington’s

In the business news section of this week’s episode, Axiom Biosciences recently announced its plans to go public and made headlines for its plans...

more new items

Beyond the Technology: AI Readiness in Regulated Laboratories

Artificial intelligence readiness involves much more than upgrading technology. For laboratories operating in regulated environments, it requires connected workflows, trusted data, effective human oversight,...

Receptor.AI and Sethera Plan to Create Closed-Loop Discovery and Optimization Workflow...

Receptor.AI and Sethera partner to create a closed-loop drug discovery workflow. Sethera will generate and experimentally screen architecture-diverse polymacrocyclic peptide libraries. Receptor.AI will apply...

Axiom’s Hong Kong Bet, Latigo’s Positive Phase II, and Base Editors...

In the business news section of this week’s episode, Axiom Biosciences recently announced its plans to go public and made headlines for its plans...